ALLMedicine™ Dyspareunia Center
Research & Reviews 1,096 results
https://clinicaltrials.gov/ct2/show/NCT04028986
May 20th, 2022 - Uterine fibroids are the most common benign uterine tumors in women of reproductive age. Symptoms are depending on size, number and localisation of the fibroids. Heavy menstrual bleeding, anaemia, abdominal pain, dyspareunia and urinary symptoms a...
https://doi.org/10.1016/j.jpag.2022.04.010
Journal of Pediatric and Adolescent Gynecology; Moussaoui D, Grover SR
May 16th, 2022 - The exposure to adverse childhood experiences (ACEs) has been associated with poor health outcomes, including chronic pain. However, little is known about the potential impact on the development of pelvic pain in adolescents and young adults. This...
https://clinicaltrials.gov/ct2/show/NCT02173405
May 10th, 2022 - BACKGROUND AND RATIONALE: Chronic pelvic pain affects 15-20% of the female population aged 18-50 years and accounts for up to 10% of gynecologic visits each year resulting in a cost of 2.8 billion dollars annually to the health care system. It is ...
https://clinicaltrials.gov/ct2/show/NCT05367089
May 10th, 2022 - The purpose of this study is to investigate the vaginal culture (positive or negative) after the application of a Medical Grade Honey formulation (L-Mesitran ®) in relation to the current standard of care (Fluconazole) 1 month after starting treat...
https://doi.org/10.12788/jfp.0365
The Journal of Family Practice; Williams AA
May 5th, 2022 - Asking the questions identified here can guide your care. Knowing which treatment options are-and aren't-supported by the evidence is also key.
Guidelines 8 results
https://doi.org/10.1097/AOG.0000000000003605
Obstetrics and Gynecology;
Dec 20th, 2019 - Vaginitis is defined as inflammation or infection of the vagina and is associated with a spectrum of symptoms, including vulvovaginal itching, burning, irritation, dyspareunia, "fishy" vaginal odor, and abnormal vaginal discharge. Vaginal symptoms...
https://doi.org/10.1097/AOG.0000000000003617
Obstetrics and Gynecology;
Dec 20th, 2019 - "Female genital cosmetic surgery" is a broad term that comprises numerous procedures, including labiaplasty, clitoral hood reduction, hymenoplasty, labia majora augmentation, vaginoplasty, and G-spot amplification. Both patient interest in and per...
https://doi.org/10.1097/AOG.0000000000003604
Obstetrics and Gynecology;
Dec 20th, 2019 - Vaginitis is defined as inflammation or infection of the vagina and is associated with a spectrum of symptoms, including vulvovaginal itching, burning, irritation, dyspareunia, "fishy" vaginal odor, and abnormal vaginal discharge. Vaginal symptoms...
https://doi.org/10.1016/j.jogc.2018.04.009
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Lamont J, Bajzak K et. al.
Jun 5th, 2018 - To establish national guidelines for the assessment of women's sexual health concerns and the provision of sexual health care for women. Published literature was retrieved through searches of PubMed, CINAHL, and the Cochrane Library from May to Oc...
https://doi.org/10.1016/j.jogc.2017.05.006
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Larouche M, Geoffrion R et. al.
Oct 31st, 2017 - This guideline reviews the evidence related to the risks and benefits of using transvaginal mesh in pelvic organ prolapse repairs in order to update recommendations initially made in 2011. Gynaecologists, residents, urologists, urogynaecologists, ...
Drugs 13 results see all →
Clinicaltrials.gov 68 results
https://clinicaltrials.gov/ct2/show/NCT04028986
May 20th, 2022 - Uterine fibroids are the most common benign uterine tumors in women of reproductive age. Symptoms are depending on size, number and localisation of the fibroids. Heavy menstrual bleeding, anaemia, abdominal pain, dyspareunia and urinary symptoms a...
https://clinicaltrials.gov/ct2/show/NCT02173405
May 10th, 2022 - BACKGROUND AND RATIONALE: Chronic pelvic pain affects 15-20% of the female population aged 18-50 years and accounts for up to 10% of gynecologic visits each year resulting in a cost of 2.8 billion dollars annually to the health care system. It is ...
https://clinicaltrials.gov/ct2/show/NCT05367089
May 10th, 2022 - The purpose of this study is to investigate the vaginal culture (positive or negative) after the application of a Medical Grade Honey formulation (L-Mesitran ®) in relation to the current standard of care (Fluconazole) 1 month after starting treat...
https://clinicaltrials.gov/ct2/show/NCT05247073
Mar 29th, 2022 - Methodology: This technique will be applied to all women with episiotomy at the time of delivery or having tears in the perineum or the vagina. The technique uses absorbable vicryl threads with round needles 75 mm long. The technique includes the ...
https://clinicaltrials.gov/ct2/show/NCT03238053
Mar 16th, 2022 - Genitourinary syndrome of menopause (GSM) is characterized by symptoms such as vaginal dryness, dyspareunia, irritation, urinary incontinence, overactive bladder , and urinary tract infections. GSM replaces the previous term vulvovaginal atrophy a...
News 206 results
https://www.mdedge.com/obgyn/article/253626/menopause/serms-revisited-can-they-improve-menopausal-care
Steven R. Goldstein, MD, NCMP, CCD
Apr 8th, 2022 - Selective estrogen receptor modulators (SERMs) are unique synthetic compounds that bind to the estrogen receptor and initiate either estrogenic agonistic or antagonistic activity, depending on the confirmational change they produce on binding to t.
https://www.medscape.com/viewarticle/970101
Mar 10th, 2022 - The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway Patients with multiple myeloma face several unique sexual challenges. These challenges are not frequently discusse...
https://www.mdedge.com/familymedicine/article/252543/pain/dyspareunia-keys-biopsychosocial-evaluation-and-treatment
MDedge Family Medicine; Adrienne A. Williams, PhD
Mar 8th, 2022 - Dyspareunia is persistent or recurrent pain before, during, or after sexual contact and is not limited to cisgender individuals or vaginal intercourse. 1-3 With a prevalence as high as 45% in the United States,2-5 it is one of the most common compl.
https://www.onclive.com/view/dr-goetz-on-adverse-events-with-aromatase-inhibitors-in-breast-cancer
Oct 6th, 2021 - Matthew P. Goetz, MD, consultant, Division of Medical Oncology, Department of Oncology, Mayo Clinic, discusses adverse events (AEs) associated with aromatase inhibitors (AIs). Arthralgia, one of the main AEs of AIs, can be mild for some patients ...
https://www.mdedge.com/obgyn/article/245928/gynecology/innovative-therapies-gynecology-evidence-and-your-practice
Miles Murphy, MD, MSPH, Cecile Ferrando, MD, MPH et. al.
Sep 9th, 2021 - As more and more gynecologic therapies move to the outpatient setting, keeping up on the latest data regarding emerging options can be challenging. Furthermore, it can be difficult to justify purchasing expensive equipment for the office when a th.